Friday, July 28, 2017
Tags The Abraaj Group

Tag: The Abraaj Group


Popular Articles

Cindat Capital appoints ex-HCP Inc exec John Stasinos as managing director

Real estate investment firm Cindat Capital has unveiled its new managing director, John Stasinos.

Yellow Wood ‘willing to take risk’ of potential market downturn with unique consumer investment...

A financial downturn many believe is on the cards over the next couple of years could spell trouble for the consumer sector - but specialist buyout firm Yellow Wood says its niche strategy in the sector is worth the risk.

Pension funds lose out to Hong Kong’s richest man in €4.5bn CVC sale of...

CVC Capital has sealed the €4.5bn sale of its German metering business Ista to a pair of companies run by Hong Kong's richest man.

Trump nominee Randal Quarles set to change Fed course and reign back banking regs

President Trump's nominee to become the first-ever vice chair for supervision on the Fed Board, Randal Quarles, has vowed to water down the banking restrictions he said helped stabilise the financial system after 2008, Bloomberg reports.

Platinum to pick up Singapore-listed engineering company Fischer Tech through take-private deal

US-based Platinum Equity is to acquire Singapore-listed global engineering company Fischer Tech in a S$3.02 ($2.22) per share take-private deal.

Linsalata launches Fund VII, small company-focused Watervale Equity

Mid-market firm Linsalata Capital Partners has launched its seventh buyout fund and managing director Michael Faremouth will lead the launch of small company focused Watervale Equity Partners.

Advent purchases majority stake in US restaurant chain First Watch

Advent International has agreed to purchase a majority stake in Freeman Spogli & Co-backed First Watch Restaurants.

Baird Capital backs biopharma consultancy business Prescient Healthcare

Robert W Baird & Co's direct investment arm has picked up a stake in London-based biopharma product strategy consultancy Prescient Healthcare Group.

LongueVue keeps up healthcare investment pace following $252m Fund III close

LongueVue Capital has followed the $252m hard cap close of its third fund with a deal for spinal implant and medical instruments business Zavation Medical Products.

ICG beats $1bn target in final close of first blind pool secondaries fundraise

Intermediate Capital Group has beaten its $1bn target for first blind-pool secondaries fundraise.